Day: August 31, 2023

PHOENIX, Aug. 31, 2023 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), the North American leader in innovative temporary space solutions, today announced that Tim Boswell, President and Chief Financial Officer, and Nick Girardi, Senior Director of Treasury and Investor Relations, will participate in a presentation and host private investor meetings at the Jefferies Industrials Conference in New York, NY, on September 6, 2023. The presentation will take place at 9:30 am ET. About WillScot Mobile Mini WillScot Mobile Mini trades on the Nasdaq stock exchange under the ticker symbol “WSC.” Headquartered in Phoenix, Arizona, the Company is a leading business services provider specializing in innovative and flexible temporary space solutions. The Company’s diverse product...

CARSON CITY, Nev., Aug. 31, 2023 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced it will host a virtual KOL event titled NE3107―Putting Data in Context, ahead of the upcoming Phase 3 results in Alzheimer’s Disease. The event will take place on Thursday, September 7, 2023 at 2:30pm ET. To register, click here. The event will focus on BioVie’s lead product candidate, NE3107, currently in a potentially pivotal Phase 3 study in patients with mild to moderate Alzheimer’s disease with expected topline data readout in the fourth quarter of 2023. The company’s leadership team and Key Opinion Leader (KOL) Steven E. Arnold, MD (Harvard Medical...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ROUYN-NORANDA, Quebec, Aug. 31, 2023 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) announces that it amends the terms of the non-brokered private placement announced in June 2023, for which no closing occurred. It is now expected to raise gross proceeds of up to $3,000,000 (the “Offering“), consisting of up to 75,000,000 units of the Corporation (the “Units“) at a price of $0.04 per Unit. Each Unit will consist of one common share of the Corporation (a “Common Share”) and one common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder thereof to purchase one Common Share at a price of $0.05 for a period of 36 months following the closing date of the Offering. It...

TEL AVIV, Israel, and MIAMI, Aug. 31, 2023 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that an abstract detailing upcoming 30-day results from its C-Guardians U.S. IDE clinical trial has been accepted for presentation as a late-breaking clinical trial at the Vascular InterVentional Advances Annual Meeting (VIVA23), which is being held October 30 through November 2 in Las Vegas. Presentation details:Title: 30-Day Results from the C-Guardians Pivotal Trial of the CGuard™ Carotid Stent SystemPresenter: Chris Metzger, M.D., System Chair of Clinical Research at Ballad Health System and lead investigator of the C-Guardians trialDate: Wednesday, November 1, 2023Time: 10:45am-12:00pm...